A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617.
Jeffrey D Bradley
No relevant relationships to disclose
Rebecca Paulus
No relevant relationships to disclose
Ritsuko Komaki
No relevant relationships to disclose
Gregory A. Masters
No relevant relationships to disclose
Kenneth Forster
No relevant relationships to disclose
Steven E. Schild
No relevant relationships to disclose
Jeffrey Bogart
No relevant relationships to disclose
Yolanda I. Garces
No relevant relationships to disclose
Samir Narayan
No relevant relationships to disclose
Vivek Kavadi
No relevant relationships to disclose
Lucien Alexander Nedzi
No relevant relationships to disclose
Jeff M. Michalski
Research Funding - National Cancer Institute grant
Douglas Johnson
No relevant relationships to disclose
Robert Malcolm MacRae
No relevant relationships to disclose
Walter John Curran
Research Funding - RTOG U10 CA21661
Hak Choy
Research Funding - RTOG U10 CA21661